GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.

Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

874 CNE100000387

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 09:05:23 2025-01-16 pm EST			5-day change	1st Jan Change
17.34 ^HKD	0.00%		+1.29%	-4.73%

Jan. 15	Guangzhou Baiyunshan Pharma Gets Local Approval to Reduce, Add Production Lines	MT
Jan. 07	Baiyunshan Pharma's Venture Capital Fund Completes Registration	MT

Guangzhou Baiyunshan Pharmaceutical's Chairperson Resigns; Shares Down 3%

July 23, 2024 at 03:12 am EDT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Guangzhou Baiyunshan Pharma Gets Local Approval to Reduce, Add Production Lines	Jan. 15	MT
Baiyunshan Pharma's Venture Capital Fund Completes Registration	Jan. 07	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Resignation of Cai Ruiyu as Chairperson of the Supervisory Committee	Dec. 24	CI
Baiyunshan Unit Gets Authorization for Indian Gooseberry Lozenge Production	Dec. 23	MT
Baiyunshan Pharmaceutical's Unit Gets Nod to Cefuroxime Sodium for Injection's Amendment	Dec. 15	MT
Baiyunshan Pharma's Unit Gets Nod to Make Changes to Selaginella Jiangnanensis Tablets	Nov. 27	MT
Baiyunshan Pharma Gets Nod to Market Anti-Tumor Drug	Nov. 27	MT
Guangzhou Baiyunshan Pharmaceutical Unit Gets Approval for Antibiotic in China	Nov. 26	MT
China Approves Baiyunshan Pharma Unit's Supplementary Application for Traditional Chinese Drug	Nov. 22	MT
Guangzhou Baiyunshan Pharmaceutical Unit Gets Additions to Drug Production License	Nov. 18	MT
Guangzhou Baiyunshan Pharmaceutical's Factory Passes Generic Drug Consistency Evaluation for Two Antibiotics	Nov. 03	MT
Baiyunshan Pharmaceutical's Q3 Profit Plunges 38%	24-10-25	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-18	CI
Guangzhou Baiyunshan Pharmaceutical Branch Gets Supplementary Drug Application for Antibiotic	24-10-16	MT
Guangzhou Baiyunshan Pharmaceutical Gets License to Expand Unit's Drug Production License	24-09-13	MT
Baiyunshan Pharma Gets China Supplemental Drug Nod for Nitroglycerin Injection for Heart Problems	24-09-10	MT
Baiyunshan Pharmaceutical's Executive Director Resigns Amid Ongoing Investigation	24-09-02	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Resignation of Mr. Zhang Chunbo as Director	24-09-01	CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-30	CI
TravelSky Technology Limited Announces Resignation of Yang Jun as Shareholder Representative Supervisor	24-08-28	CI
Guangzhou Baiyunshan Secures Marketing Authorization for Compound Acetaminophen Granules	24-08-19	MT
Guangzhou Baiyunshan Pharmaceutical Passes Quality, Consistency Evaluation for Antibiotic	24-08-12	MT
Baiyunshan Pharmaceutical to Build Guangzhou Factory For 3.2 Billion Yuan	24-08-05	MT
Guangzhou Baiyunshan Pharmaceutical's Chairperson Resigns; Shares Down 3%	24-07-23	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Board Changes	24-07-22	CI

Chart Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Duration

Period

Chart Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

874: Dynamic Chart

Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. specializes in researching, developing and manufacturing pharmaceutical products. The group's products include analgesics, antibiotics, medicines for the treatment of stomach disorders, treatment of cough, antitoxic products, etc.

Employees

28,048

Sector

Pharmaceuticals

Calendar

2025-03-16 - Q4 2024 Earnings Release (Projected)

More about the company